Ichor Biologics reportedly seeks $80–100 million in minority stake sale

The Economic Times reports that the Hyderabad-based maker of therapeutic proteins derived from human plasma is seeking private equity funding.

2 Sources, 22d ago, first seen 22d ago

TLDR

Ichor Biologics is seeking $80–100 million from private equity investors through a minority stake sale, The Economic Times reports. The company specializes in plasma-based therapies, manufacturing therapeutic protein products derived from human plasma.

Today's Rank

—

Not ranked yet

Combined views

2 Sources, first seen 22d ago

Sentiment

Positive——Negative

Summary

Not enough discussion yet.

No sentiment analysis available yet.

Featured Source